Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Company Description (as filed with the SEC)
We are a diversified healthcare company that seeks to establish industry-leading positions in large and rapidly growing medical markets. Our diagnostics business includes Bio-Reference Laboratories ("Bio-Reference"), the nation's third-largest clinical laboratory with a core genetic testing business and a 420-person sales force to drive growth and leverage new products, including the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. Our pharmaceutical business features Rayaldee, a treatment for secondary hyperparathyroidism ("SHPT") in patients with stage 3 or 4 chronic kidney disease ("CKD") and vitamin D insufficiency (target March 29, 2016 PDUFA date) and VARUBI(TM) for chemotherapy-induced nausea and vomiting (launched by partner TESARO in November 2015). ... More ...
Where does OPK fit in the risk graph?
|Annual EPS Est:||$0.15|
|Quarterly EPS Est:||-0.01|